← brief for 2026-10-09 · Slowing decline

Beyond efficacy: the treatment lifecycle of incretin and multi-receptor agonists.

Paper No results yet Peer reviewed

Key takeaways

This review looks at how new weight-loss and diabetes drugs affect the heart and kidneys. It discusses how these drugs are used over time in real life. It does not report new trial results.

Who did this work

Rabbani SA · El-Tanani M · Matalka II · Rizzo M

Source

Paper · PubMed, the drug frontier · 2026 Sep 24
https://pubmed.ncbi.nlm.nih.gov/42851902/